SCHEMBL25725210

SCHEMBL25725210

N#CN1CCC2(CC1)CN(c1ncnc3ccc(CCc4cccnc4)cc13)C2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 9/20 0.41
▸ CYP3A4 P08684 9/20 0.41
▸ ALDH1A1 P00352 6/20 0.41
▸ CLK4 Q9HAZ1 6/20 0.41
▸ KDM4E B2RXH2 5/20 0.41
▸ MEN1 O00255 5/20 0.41
▸ KMT2A Q03164 5/20 0.41
▸ CYP2D6 P10635 3/20 0.41
▸ LMNA P02545 2/20 0.41
▸ ALOX15 P16050 1/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ PDGFRB P09619 4/20 0.40
▸ PDGFRA P16234 4/20 0.40
▸ HSD17B10 Q99714 4/20 0.39
▸ CYP2C19 P33261 3/20 0.39
▸ HPGD P15428 4/20 0.37
▸ HIF1A Q16665 2/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ RXFP1 Q9HBX9 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25630561 0.89 KIT (0.41) CYP1A2CYP3A4ALDH1A1CLK4KDM4E
SCHEMBL31027439 0.85 CYP1A2 (0.51) CYP1A2CYP3A4ALDH1A1CLK4KDM4E
SCHEMBL25276551 0.85 CYP1A2 (0.51) CYP1A2CYP3A4ALDH1A1CLK4KDM4E
SCHEMBL31501681 0.85 CYP1A2 (0.51) CYP1A2CYP3A4ALDH1A1CLK4KDM4E
SCHEMBL25275689 0.84 PDGFRB (0.43) CYP1A2CYP3A4ALDH1A1CLK4KDM4E
SCHEMBL25631166 0.82 HTT (0.35) CYP1A2CYP3A4ALDH1A1CLK4KDM4E
SCHEMBL30406053 0.80 KIT (0.51) CYP1A2CYP3A4ALDH1A1CLK4MEN1
SCHEMBL25437390 0.80 KIT (0.51) CYP1A2CYP3A4ALDH1A1CLK4MEN1
SCHEMBL30405196 0.78 PDGFRB (0.41) CYP1A2CYP3A4ALDH1A1CLK4MEN1
SCHEMBL25630530 0.76 PTK2 (0.50) CYP1A2CYP3A4ALDH1A1CLK4KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023107696-A2 INHIBITORS OF MENIN-MLL INTERACTION BALA THERAPEUTICS, INC. (US) 2023-06-15 — — WO disclosed
Send feedback